Tennessee Oncology is home to one of the leading clinical trial networks in the country. We offer a broad menu of trial opportunities in every phase of treatment. Use the search below to discover and learn more about our clinical trials:
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (SubQSA)
Condition: Multiple Myeloma
TO Study: MM24003
Clinic:
Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mount Juliet, Murfreesboro, Skyline, Southern Hills, St. Thomas West, Ringgold, Shelbyville, Smyrna, Chattanooga Downtown, Med Park 2, Memorial, Cleveland, Dalton, Dickson
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 (HARMONi-7)
Condition: Non-small Cell Lung Cancer
TO Study: LUN25082
Clinic:
Chattanooga Downtown, Chattanooga East, Cleveland, Dalton, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Med Park 2, Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West
A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013) (INTerpath-13)
Condition: Non-small Cell Lung Cancer
TO Study: LUN25070
Clinic:
Dickson, Skyline, Hendersonville, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Med Park 2, Memorial
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract (FORAGER-2)
Condition: Urothelial Cancer
TO Study: GU25026
Clinic:
Cleveland, Cookeville, Chattanooga Downtown, Dalton, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Med Park 2, Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer (HARMONi-GI3)
Condition: Colorectal Cancer
TO Study: GI24021
Clinic:
Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Lebanon, Hendersonville, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Condition: Pancreatic Ductal Adenocarcinoma
TO Study: GI25022
Clinic:
Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Lebanon, Hendersonville, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors (ARC-20)
Condition: Renal Cell Carcinoma
TO Study: GU25021
Clinic:
Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Med Park 2, Memorial, Chattanooga East
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy (TRILLIUM)
Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
TO Study: LUN25066
Clinic:
Dickson, Skyline, Hendersonville, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Med Park 2, Memorial, Ringgold, Dalton
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Condition: Non-small Cell Lung Cancer
TO Study: LUN25064
Clinic:
Dickson, Skyline, Hendersonville, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Med Park 2, Memorial, Ringgold, Dalton
ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
TO Study: LUN24057
Clinic:
Lebanon, Cookeville, Hendersonville, Gallatin, Franklin, Med Park 2, Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Skyline, Smyrna, Cleveland, Chattanooga Downtown, Southern Hills, St. Thomas West
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/?INTerpath-009)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24039
Clinic:
Dickson, Skyline, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Med Park 2, Memorial, Ringgold, Dalton
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Condition: Non-small Cell Lung Cancer
TO Study: MULTI24013
Clinic:
Dickson, Skyline, Hendersonville, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Med Park 2, Memorial
A Phase I/?II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (Lumi-NHL)
Condition: Follicular Lymphoma, Large B-Cell Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (Morpheus-panBC)
Condition: Breast Cancer
TO Study: BRE24018
Clinic:
Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Midtown, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer (ReDiscover-2)
Condition: Breast Cancer
TO Study: BRE25026
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Midtown, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Southern Hills, Mt. Juliet
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/?Refractory Diffuse Large B-Cell Lymphoma
Condition: Large B-Cell Lymphoma
TO Study: LYM24024
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC (PACIFIC-8)
Condition: Non-small Cell Lung Cancer
TO Study: LUN25073
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations
Condition: Non-small Cell Lung Cancer
TO Study: LUN24045
Clinic:
Dickson, Skyline, Hendersonville, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Med Park 2, Memorial, Ringgold, Dalton
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer (NeoCOAST-2)
Condition: Non-small Cell Lung Cancer
TO Study: LUN 494
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) (KLK2-comPAS)
Condition: Prostate Cancer
TO Study: GU24014
Clinic:
Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
TO Study: CLL24007
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
Condition: Multiple Myeloma
TO Study: MM24009
Clinic:
Elliston Place Plaza, Murfreesboro, Smyrna, Chattanooga Downtown, Med Park 2, Memorial
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer (SUNRAY-02)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24050
Clinic:
Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
Study of Olverembatinib (HQP1351) in Patients With CP-CML (POLARIS-2)
Condition: Chronic Myeloid Leukemia
TO Study: CML24002
Clinic:
Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR
Condition: Breast Cancer
TO Study: BRE24016
Clinic:
Elliston Place Plaza, Lebanon, Smyrna, Southern Hills, Murfreesboro, Mt. Juliet, St. Thomas West, Shelbyville, Chattanooga Downtown, Med Park 2, Memorial
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer (EvoPAR-BR01)
Condition: Breast Cancer
TO Study: BRE23007
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (DREAMM-20)
Condition: Multiple Myeloma
TO Study: MM24013
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
TO Study: CLL23001
Clinic:
Dickson, Franklin, Gallatin, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Mt. Juliet, Cleveland, Chattanooga Downtown, Med Park 2, Memorial
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) (INTerpath-002)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24037
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
Condition: Colorectal Cancer
TO Study: GI24010
Clinic:
Lebanon, Murfreesboro, Chattanooga Downtown, Med Park 2, Memorial
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/?Refractory Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
TO Study: LYM24022
Clinic:
St. Thomas West, Elliston Place Plaza, Cleveland, Chattanooga Downtown, Med Park 2, Memorial
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24026
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer (SUNRAY-01)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24032
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator’s Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer (rechARge)
Condition: Prostate Cancer
TO Study: GU24007
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Downtown, Chattanooga East, Dalton, Med Park 2, Memorial, Ringgold
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (ELEGANT)
Condition: Breast Cancer
TO Study: BRE24013
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Southern Hills, Smyrna, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-negative Metastatic Triple Negative Breast Cancer (TNBC)
Condition: Breast Cancer
TO Study: BRE 360
Clinic:
Cleveland, Chattanooga Downtown, Med Park 2, Memorial
Phase 2 Open-label Study to Evaluate Momelotinib in Combination with Luspatercept in Participants with Transfusion Dependent Primary or Secondary Myelofibrosis
Condition: Myelofibrosis
TO Study: MPN24004
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Med Park 2, Memorial
A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Condition: Myelofibrosis
TO Study: MPN24003
Clinic:
Cleveland, Chattanooga Downtown, Med Park 2, Memorial, Dalton, Ringgold, Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Elliston Place Plaza
A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (CAMMOUFLAGE Trial)
A Phase 1 Study of KTX-1001, an Oral, First-In-Class, Selective, and Potent MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma
A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies
An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel versus Standard of Care Treatment as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma (ZUMA-23)
A Phase 1, Dose Escalation, Safety and Tolerability Study of NX-2127, a Bruton’s Tyrosine Kinase (BTK) Degrader, in Adults with Relapsed/Refractory B-cell Malignancies.
Condition: Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Primary Central Nervous System Lymphoma, Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia
A randomized, open-label, phase 3 trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic Non-Small Cell Lung Cancer (NSCLC) and secondary resistance to Immune Checkpoint Inhibitor (ICI)- ARTEMIA…
Condition: Non-small Cell Lung Cancer
TO Study: LUN24016
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared with Investigator’s Choice Monotherapy Treatment in Previously Treated Patients with Incurable, Metastatic/recurrent Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
TO Study: HN23003
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR – HN1)
Condition: Head and Neck Squamous Cell Carcinoma
TO Study: HN24004
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Southern Hills, Mt. Juliet, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
TO Study: LUN23013
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills
A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants with EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer whose Disease has Progressed on…
Condition: Non-small Cell Lung Cancer
TO Study: LUN24015
Clinic:
Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet
A Phase III, Randomized, Double-Blind, Multicenter, Global Study of Rilvegostomig in Combination with Chemotherapy for First-line Treatment of Patients with Metastatic Non-squamous Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung03)
Condition: Non-small Cell Lung Cancer
TO Study: LUN24029
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma (JADE)
Condition: Head and Neck Squamous Cell Carcinoma
TO Study: HN23002
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/?NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy (OrigAMI-3)
Condition: Colorectal Cancer
TO Study: GI24012
Clinic:
Elliston Place Plaza, Murfreesboro, Smyrna, Chattanooga Downtown, Med Park 2, Memorial
First-in-Human, Open-Label, Phase 1/2 Dose-Escalation with Enrichment and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of GIM-122 as a Single Agent in Adult Subjects with Advanced Solid Malignancies
Phase 1/2, Open-label, Multi-center Study of the Safety, Tolerability, and Efficacy of GIM-531 as a Single Agent and in Combination with Anti-PD-1 in Advanced Solid Tumors
A Phase Ib/III Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer…
Condition: Breast Cancer
TO Study: BRE24011
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville
A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive…
Condition: Breast Cancer
TO Study: BRE23006
Clinic:
Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Med Park 2, Memorial, Ringgold
